Puma Biotechnology | PBYI - إيرادات الفوائد





إيرادات الفوائد تغيير تاريخ
Agios Pharmaceuticals USD 13.37M 1.14M 2025-09
Alnylam Pharmaceuticals USD 28.68M 1.19M 2025-09
Biogen USD 31.6M 700K 2025-09
BioMarin Pharmaceutical USD 17.85M 973K 2025-09
Daiichi Sankyo JPY 9.96B 230M 2024-03
Esperion Therapeutics USD -0.15 0.18 2024-09
Exelixis USD 15.92M 867K 2025-09
Gilead Sciences USD 88M 15M 2025-09
Glaxosmithkline GBP 26M 24M 2025-09
Incyte USD 30.75M 3.97M 2025-12
MacroGenics USD 1.53M 114K 2025-09
Moderna USD 73M 8M 2025-09
Pfizer USD 0.62 156M 2025-09
Puma Biotechnology USD 0.41 0.5 2024-09
Regeneron Pharmaceuticals USD 175.1M 300K 2025-09
Sarepta Therapeutics USD 8.38M 1.24M 2025-09
Takeda JPY 87.87B 43.48B 2025-12
Ultragenyx Pharmaceutical USD 5.86M 69K 2025-09
Vertex Pharmaceuticals USD 125.7M 3.3M 2025-09